OnKure Therapeutics, Inc. Class A Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, OnKure Therapeutics, Inc. Class A Common Stock (OKUR) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.8%, relative volume 7.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
36 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
OKUR is in a stage 2 uptrend, week 1. Currently in a 39-day base; basing ADR 8.4% (broad 8.3%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 5.4% / 33.4%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
OKUR is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $299K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OKUR Jan avg: -18.73% median: -18.73% win: 0% σ: 13.80% n: 2 2024-10-08 → 2026-05-29 | OKUR Feb avg: -7.46% median: -7.46% win: 50% σ: 14.29% n: 2 2024-10-08 → 2026-05-29 | OKUR Mar avg: 18.79% median: 18.79% win: 50% σ: 48.05% n: 2 2024-10-08 → 2026-05-29 | OKUR Apr avg: -7.40% median: -7.40% win: 50% σ: 49.06% n: 2 2024-10-08 → 2026-05-29 | OKUR May avg: -9.35% median: -9.35% win: 50% σ: 15.49% n: 2 2024-10-08 → 2026-05-29 | OKUR Jun avg: -5.53% median: -5.53% win: 0% σ: 0.00% n: 1 2024-10-08 → 2026-05-29 (current) | OKUR Jul avg: -7.53% median: -7.53% win: 0% σ: 0.00% n: 1 2024-10-08 → 2026-05-29 | OKUR Aug avg: 24.43% median: 24.43% win: 100% σ: 0.00% n: 1 2024-10-08 → 2026-05-29 | OKUR Sep avg: 0.00% median: 0.00% win: 0% σ: 0.00% n: 1 2024-10-08 → 2026-05-29 | OKUR Oct avg: 8.55% median: 8.55% win: 50% σ: 20.82% n: 2 2024-10-08 → 2026-05-29 | OKUR Nov avg: -11.55% median: -11.55% win: 0% σ: 0.48% n: 2 2024-10-08 → 2026-05-29 | OKUR Dec avg: -23.94% median: -23.94% win: 0% σ: 28.69% n: 2 2024-10-08 → 2026-05-29 |